Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses. (Q51477256)
Jump to navigation
Jump to search
scientific article published in August 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses. |
scientific article published in August 2011 |
Statements
Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses (English)
Shi-Jun He
Xin Li
Yang Yang
Pei-Lan He
Yu Zhou
Feng-Hua Zhu
Yi-Fu Yang
Ying Li
Wei Tang
Jian-Ping Zuo
1 August 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference